Regenxbio News

Regenxbio Analyst Ratings

BenzingaSep 5 00:37

HC Wainwright & Co. Reiterates Buy on Regenxbio, Maintains $39 Price Target

BenzingaSep 5 00:36

H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $39

Futu NewsSep 4 23:31

Positive Clinical Trials and Regulatory Milestones Bolster Buy Rating for RegenXBio

TipRanksSep 4 23:09

Barclays Maintains Overweight on Regenxbio, Lowers Price Target to $50

BenzingaAug 6 07:53

Regenxbio Analyst Ratings

BenzingaAug 5 19:05

HC Wainwright & Co. Maintains Buy on Regenxbio, Raises Price Target to $39

BenzingaAug 5 19:04

H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Raises Target Price to $39

Futu NewsAug 5 18:31

Barclays Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $50

Futu NewsAug 5 16:32

Buy Rating Affirmed for RegenXBio on Strong Clinical Updates and Strategic FDA Engagements

TipRanksAug 5 14:20

Analysts Are Bullish on Top Healthcare Stocks: Twist Bioscience (TWST), RegenXBio (RGNX)

TipRanksAug 5 09:43

RegenXBio (RGNX) Receives a Buy From Stifel Nicolaus

TipRanksAug 2 20:56

Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT), RegenXBio (RGNX) and Laboratory (LH)

TipRanksAug 2 20:56

Stifel Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $40

Futu NewsAug 2 20:35

RBC Capital Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $35

Futu NewsAug 2 19:31

RBC Capital Sticks to Their Buy Rating for RegenXBio (RGNX)

TipRanksAug 2 18:49

Stifel Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $40

Futu NewsJul 29 20:31

Analysts' Top Healthcare Picks: KalVista Pharmaceuticals (KALV), RegenXBio (RGNX)

TipRanksJul 29 19:51

RBC Capital Remains a Buy on RegenXBio (RGNX)

TipRanksJul 22 14:01

Regenxbio Analyst Ratings

BenzingaJun 20 23:27